✦ LIBER ✦

14LBA Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)

✍ Scribed by M. Peeters; T. Price; Y. Hotko; A. Cervantes; M. Ducreux; T. André; E. Chan; F. Lordick; A. Rong; J. Gansert

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6083 Final results from PRECEPT: efficac

✍ Cohn, A.; Smith, D.A.; Neubauer, M.A.; Richards, D.; Watkins, D.L.; Zhang, K.; Y 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

10LBA Randomized phase 3 study of panitu

✍ J. Douillard; S. Siena; J. Cassidy; J. Tabernero; R. Burkes; M.E. Barugel; Y. Hu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

An Open-label, Single-arm, Phase 2 Trial

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

Skin toxicity and quality of life in pat

✍ Josef Thaler, Meinolf Karthaus, Laurent Mineur, Richard Greil, Henry Letocha, Ra 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 226 KB

Results From VELOUR, a Phase 3 Study of

✍ J. Tabernero; E. Van Cutsem; R. Lakomy; J. Prausova; P. Ruff; G. Van Hazel; V Mo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

6095 POSTER Randomized, Open-label, Phas

✍ Burkes, R.; Siena, S.; Cassidy, J.; Tabernero, J.; Barugel, M.E.; Humblet, Y.; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB